Figure 2 | Scientific Reports

Figure 2

From: Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer

Figure 2

Predictive targets of naringenin and cervical cancer. (A) Identification of differentially expressed genes (DEGs) in cervical cancer versus normal cervical tissues. Downregulated genes are represented in blue and upregulated genes in red. (B) The Venn diagram illustrating common targets in cervical cancer and naringenin. (C) Targets of naringenin relevant to cervical cancer.

Back to article page